Merck & Co Inc Cardiovascular Event Transcript
Good morning. My name is Grace Lacker, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co., Inc.'s Cardiovascular Investor Event. (Operator Instructions) I would now like to turn the call over to Peter Dannenbaum, Vice President of Investor Relations. Please go ahead.
Thank you, Grace, and good morning, everyone. Welcome to Merck's Cardiovascular Investor Event. We are excited to have this opportunity to speak to you today about our broad and growing cardiovascular portfolio. During today's call, a slide presentation will accompany our speakers' prepared remarks. This presentation is posted to the Investor Relations section of Merck's website.
Speaking on today's call will be Eliav Barr, Senior Vice President, Head of Global Clinical Development and Chief Medical Officer; Arpa Garay, Chief Marketing Officer, Human Health; Joerg Koglin, Vice President, Global Clinical Development, Cardiovascular and Respiratory; Dean Li, President, Merck
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |